Aktis Oncology, Inc. (AKTS) Ownership - Who Owns Aktis Oncology, Inc.?

27 Followers

Aktis Oncology, Inc. (AKTS) Ownership Overview

47.63% Insiders

44.02% Other Institutional Investors

3.42% ETFs

4.94% Public Companies and

Individual Investors

The ownership structure of Aktis Oncology, Inc. (AKTS) stock is a mix of institutional, retail, and individual investors. , 47.63% is owned by Insiders, and 4.94% is owned by Public Companies and Individual Investors.

The ownership structure of Aktis Oncology, Inc. (AKTS) stock is a mix of institutional, retail, and individual investors. Approximately 47.43% of the company’s stock is owned by Institutional Investors, 47.63% is owned by Insiders, and 4.94% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Jan 14, 2026	Ansbert Gadicke	xxxxxxxxxxxxx	$20029986
Jan 14, 2026	Mpm Bioventures 2018, L.p.	xxxxxxxxxxxxx	$20029986
Jan 14, 2026	Todd Foley	xxxxxxxxxxxxx	$4191660
Jan 12, 2026	Ecor1 Capital, Llc	xxxxxxxxxxxxx	$39999996

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2026	Baker Bros Advisors Lp	xxxxxxxxxxxxx	$17824719
Mar 31, 2026	Soros Fund Mangment Llc	xxxxxxxxxxxxx	$1789000
Mar 31, 2026	Driehaus Capital Management Llc	xxxxxxxxxxxxx	$2683500
Mar 31, 2026	Ra Capital Management	xxxxxxxxxxxxx	$26890173

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	10,260,064	Insider	19.21%	247,164,942
	10,260,064	Insider	19.21%	247,164,942
	4,235,403	Insider	7.93%	102,030,858
Peter Kolchinsky	1,503,084	Institution	2.81%	36,209,294
Felix Baker	996,351	Institution	1.87%	24,002,096
	942,238	Institution	1.76%	22,698,513
	704,431	Institution	1.32%	16,969,743
	347,305	Insider	0.65%	8,366,577
	157,387	Insider	0.29%	3,791,453
	157,387	Insider	0.29%	3,791,453

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	605,835	Institution	1.13%	12,565,018
iShares Russell 2000 ETF	478,243	Institution	0.90%	11,520,874
Vanguard Extended Market ETF	211,381	Institution	0.40%	4,384,042
Vanguard Russell 2000 ETF	105,593	Institution	0.20%	2,189,999
Schwab U.S. Small-Cap ETF	88,469	Institution	0.17%	2,081,676
iShares Russell 2000 Growth ETF	87,199	Institution	0.16%	2,100,624
iShares Russell 2000 Value ETF	81,883	Institution	0.15%	1,972,561
iShares Core S&P Total U.S. Stock Market ETF	47,769	Institution	0.09%	1,150,755
Virtus LifeSci Biotech Clinical Trials ETF	14,173	Institution	0.03%	341,428
Schwab U.S. Broad Market ETF	13,916	Institution	0.03%	327,443

FAQ

Who Owns Aktis Oncology, Inc. (AKTS)?

According to the latest TipRanks data, approximately 44.02% of the company's stock is held by institutional investors, 47.63% is held by insiders, and 4.94% is held by retail investors.

What percentage of Aktis Oncology, Inc. (AKTS) stock is held by institutional investors?

According to the latest TipRanks data, approximately 44.02% of Aktis Oncology, Inc. (AKTS) stock is held by institutional investors.

What percentage of Aktis Oncology, Inc. (AKTS) stock is held by retail investors?

According to the latest TipRanks data, approximately 4.94% of Aktis Oncology, Inc. (AKTS) stock is held by retail investors.

Who owns the most shares of Aktis Oncology, Inc. (AKTS)?

Ansbert Gadicke owns the most shares of Aktis Oncology, Inc. (AKTS).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.